Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Daunorubicin

An anticancer antibiotic of the anthracycline family, produced by the soil bacterium Streptomyces peucetius. Discovered in Italy between the 1950s and 1960s and, almost at the same time, in France, it is used mainly against acute myeloid leukaemia; in the United States since 1979. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?The name combines the Dauni, the ancient people of Apulia where the soil sample was collected near Castel del Monte, and rubis, French for ruby, for its red colour.

DaunorubicinGo to the active ingredient →
DaunorubicinActive ingredientDaunorubicinCat. No. P-D025-001CAS 20830-81-3
Baumycin C1ImpurityBaumycin C1Cat. No. P-D025-015CAS 63084-42-4
Feudomycin BPharmacopoeial impurityFeudomycin BCat. No. P-D025-027CAS 79438-97-4

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.